A Phase 2 Investigator Initiated Study to Determine the Efficacy and Safety of TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma
Phase of Trial: Phase II
Latest Information Update: 11 Aug 2017
At a glance
- Drugs Bevacizumab (Primary) ; TVB 2640 (Primary)
- Indications Astrocytoma; Glioblastoma
- Focus Therapeutic Use
- 07 Aug 2017 Status changed from not yet recruiting to recruiting.
- 02 Jun 2017 Trial design presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 24 Apr 2017 Planned initiation date changed from 10 Apr 2017 to 10 Jun 2017.